Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Major Depressive Disorder (MDD) is a prevalent, chronic, disabling, and multidimensional mental disorder. Cognitive dysfunction represents a core diagnostic and symptomatic criterion of MDD, and is a principal determinant of functional non-recovery. Cognitive impairment has been observed to persist despite remission of mood symptoms, suggesting dissociability of mood and cognitive symptoms in MDD. Recurrent impairments in several domains including, but not limited to, executive function, learning and memory, processing speed, and attention and concentration, are associated with poor psychosocial and occupational outcomes. Attempts to restore premorbid functioning in individuals with MDD requires regular screenings and assessment of objective and subjective measures of cognition by clinicians. Easily accessible and cost-effective tools such as the THINC-integrated tool (THINC-it) are suitable for use in a busy clinical environment and appear to be promising for routine usage in clinical settings. However, antidepressant treatments targeting specific cognitive domains in MDD have been insufficiently studied. While select antidepressants, e.g., vortioxetine, have been demonstrated to have direct and independent pro-cognitive effects in adults with MDD, research on additional agents remains nascent. A comprehensive clinical approach to cognitive impairments in MDD is required. The current narrative review aims to delineate the importance and relevance of cognitive dysfunction as a symptomatic target for prevention and treatment in the phenomenology of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“Brain imaging evidence in MDD reveals a pattern of increased activity in the limbic system coincident with decreased activity in executive areas of the brain (49).”
BackgroundCognitive vulnerability to emotional disorders
Mathews, A., & MacLeod, C. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143916 · Cited by 2,100
The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry
Insel, T. R. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020138 · Cited by 1,472
Pascual-Leone, A., Rubio, B., Pallardó, F., & Catalá, M. D. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01219-6 · Cited by 1,229
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800702 · Cited by 1,066 · cited 1×
“The use of CBT in combination with pharmacotherapy in adult depression has been shown to target primarily hot cognitive processes and be more effective than pharmacotherapy alone (54).”
BackgroundCognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.409 · Cited by 989 · cited 5×
“Cognitive behavior therapy (CBT) is a well-studied and propitious therapeutic avenue for the treatment andmanagement of cognitive dysfunction inMDD.”
BackgroundInfluentialMcIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765
Self-citationIn Search of the Emotional Self: An fMRI Study Using Positive and Negative Emotional Words
Fossati, P., Hevenor, S. J., Graham, S. J., Grady, C., Keightley, M. L., Craik, F., & Mayberg, H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1938 · Cited by 635 · cited 1×
“However, it is important to note that the weighted significance and distinction between “hot” and “cold” cognition in depressed individuals is non-discrete and there are many overlapping features between the two constructs (20, 21).”
BackgroundCognitive impairment in euthymic major depressive disorder: a meta-analysis
Bora, E., Harrison, B. J., Yücel, M., & Pantelis, C. (2013) · Psychological Medicine · doi:10.1017/s0033291712002085 · Cited by 551
Attention and executive functions in remitted major depression patients
Paelecke-Habermann, Y., Pohl, J., & Leplow, B. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.09.006 · Cited by 487
Neurocognitive deficits and disability in major depressive disorder
Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.11.011 · Cited by 484
White matter hyperintensities in late life depression: a systematic review
Herrmann, L. L., Le Masurier, M., & Ebmeier, K. P. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.124651 · Cited by 456
Neurocognitive Mechanisms in Depression: Implications for Treatment
Clark, L., Chamberlain, S. R., & Sahakian, B. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125618 · Cited by 446
Katona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283542457 · Cited by 445 · cited 2×
“Significant improvements on the RAVLT were found in patients treated with duloxetine; however, significant improvements on both the RAVLT and DSST were found in patients treated with vortioxetine (73).”
BackgroundMethodMcIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000546 · Cited by 433
Self-citationExercise and the treatment of depression: A review of the exercise program variables
Stanton, R., & Reaburn, P. (2014) · Journal of Science and Medicine in Sport · doi:10.1016/j.jsams.2013.03.010 · Cited by 410 · cited 2×
“Replicated evidence implicates adjunctive exercise as an effective method for reducing depressive symptoms (88), with effects observed at levels commonly recommended for general public health (89).”
BackgroundMethodCognitive impairment in the remitted state of unipolar depressive disorder: A systematic review
Hasselbalch, B. J., Knorr, U., & Kessing, L. V. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.011 · Cited by 406
Birnbaum, H. G., Kessler, R. C., Kelley, D., Ben-Hamadi, R., Joish, V. N., & Greenberg, P. E. (2010) · Depression and Anxiety · doi:10.1002/da.20580 · Cited by 380
Hot and cold cognition in depression
Roiser, J. P., & Sahakian, B. J. (2013) · CNS Spectrums · doi:10.1017/s1092852913000072 · Cited by 354 · cited 4×
“, selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), antipsychotics] with potentially adverse effects on cognitive measures (20).”
BackgroundMethodInfluentialRaskin, J., Wiltse, C. G., Siegal, A., Sheikh, J., Xu, J., Dinkel, J. J., Rotz, B. T., & Mohs, R. C. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.900 · Cited by 329
Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv082 · Cited by 315
Self-citationThe use of ketamine as an antidepressant: a systematic review and meta‐analysis
Coyle, C. M., & Laws, K. R. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2475 · Cited by 279
Gualtieri, C. T., & Morgan, D. W. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0712 · Cited by 275
Evidence for clinical progression of unipolar and bipolar disorders
Kessing, L. V., & Andersen, P. K. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12667 · Cited by 179
The role of cognitive dysfunction in the symptoms and remission from depression
Gonda, X., Pompili, M., Serafini, G., Carvalho, A. F., Rihmer, Z., & Dome, P. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0068-9 · Cited by 173
McIntyre, R. S., Best, M. W., Bowie, C. R., Carmona, N. E., Cha, D. S., Lee, Y., Subramaniapillai, M., Mansur, R. B., Barry, H., Baune, B. T., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11329 · Cited by 172
Self-citationHerrera-Guzmán, I., Gudayol-Ferré, E., Herrera-Guzmán, D., Guàrdia-Olmos, J., Hinojosa-Calvo, E., & Herrera-Abarca, J. E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.015 · Cited by 160
Papakostas, G. I. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08710 · Cited by 153
McIntyre, R. S., Xiao, H. X., Syeda, K., Vinberg, M., Carvalho, A. F., Mansur, R. B., Maruschak, N., & Cha, D. S. (2015) · CNS Drugs · doi:10.1007/s40263-015-0263-x · Cited by 145 · cited 3×
“Moreover, when treating MDD, cognitive impairments are often found to persist during periods of symptomatic remission (14), supporting the disconnect between emotional and functional improvement.”
BackgroundInfluentialSelf-citationBowie, C. R., Gupta, M., Holshausen, K., Jokic, R., Best, M., & Milev, R. (2013) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e31829c5030 · Cited by 136 · cited 1×
“Psychological methods have been proposed for the treatment and management of neurocognitive impairments in disparate neuropsychiatric conditions including MDD (48).”
MethodMediators of the association between depression and role functioning
Buist‐Bouwman, M. A., Ormel, J., De Graaf, R., De Jonge, P., Van Sonderen, E., Alonso, J., Bruffaerts, R., Vollebergh, W. A. M., & the ESEMeD/MHEDEA 2000 investigators (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01285.x · Cited by 127
Cognitive deficits in the euthymic phase of unipolar depression
Preiss, M., Kucerova, H., Lukavsky, J., Stepankova, H., Sos, P., & Kawaciukova, R. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.042 · Cited by 127 · cited 6×
“Selfreported measures of diminished concentration and attention are frequently observed in individuals presenting with MDE as part of MDD.”
BackgroundInfluentialAerobic Endurance Exercise Improves Executive Functions in Depressed Patients
Kubesch, S., Bretschneider, V., Freudenmann, R., Weidenhammer, N., Lehmann, M., Spitzer, M., & Grön, G. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0905 · Cited by 125 · cited 2×
“Aerobic/resistance exercise is also evidenced as a beneficial adjunctive therapeutic option for cognitive improvement in MDD (87).”
BackgroundNaismith, S. L., Redoblado-Hodge, M. A., Lewis, S. J. G., Scott, E. M., & Hickie, I. B. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.028 · Cited by 122 · cited 1×
“NEAR involves the delivery of individuallytailored and commercially available computer games in a group setting; the games are tailored to an individual’s strengths and weaknesses to promote learning via positive reinforcement (51).”
BackgroundHerrera-Guzmán, I., Herrera-Abarca, J. E., Gudayol-Ferré, E., Herrera-Guzmán, D., Gómez-Carbajal, L., Peña-Olvira, M., Villuendas-González, E., & Joan, G.-O. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.006 · Cited by 120
Psychiatric safety of ketamine in psychopharmacology research
Perry, E. B., Cramer, J. A., Cho, H.-S., Petrakis, I. L., Karper, L. P., Genovese, A., O’Donnell, E., Krystal, J. H., D’Souza, D. C., & Yale Ketamine Study Group (2007) · Psychopharmacology · doi:10.1007/s00213-007-0706-2 · Cited by 117
Rong, C., Park, C., Rosenblat, J. D., Subramaniapillai, M., Zuckerman, H., Fus, D., Lee, Y. L., Pan, Z., Brietzke, E., Mansur, R. B., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15040771 · Cited by 114 · cited 1×
“In particular, lower levels of baseline neurocognitive performance in individuals with TRD were correlated with an increased antidepressant response to ketamine, as indicated by a ≥50% reduction in MADRS scores (83).”
BackgroundSelf-citationCognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
Self-citationCallaghan, P., Khalil, E., Morres, I., & Carter, T. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-465 · Cited by 105
Miskowiak, K. W., Vinberg, M., Christensen, E. M., Bukh, J. D., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.335 · Cited by 104
Serafini, G., Pompili, M., Belvederi Murri, M., Respino, M., Ghio, L., Girardi, P., Fitzgerald, P. B., & Amore, M. (2015) · Neuropsychobiology · doi:10.1159/000381351 · Cited by 101
Porter, R. J., Bowie, C. R., Jordan, J., & Malhi, G. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413502090 · Cited by 85
Cognition in major depressive disorder: a ‘Systemically Important Functional Index’ (SIFI)
McIntyre, R. S., & Lee, Y. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000221 · Cited by 85
Self-citationA New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect
Lee, Y., Syeda, K., Maruschak, N. A., Cha, D. S., Mansur, R. B., Wium-Andersen, I. K., Woldeyohannes, H. O., Rosenblat, J. D., & McIntyre, R. S. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000441 · Cited by 74
Self-citationCognition as predictor of current and follow-up depressive symptoms in the general population
Simons, C. J. P., Jacobs, N., Derom, C., Thiery, E., Jolles, J., Van Os, J., & Krabbendam, L. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01339.x · Cited by 64 · cited 1×
“Moreover, a separate study evaluating longitudinal profiles of depressive symptoms in a birth cohort found that depression is associated with neurodevelopmental impairments which may be mediated by cognition (35).”
BackgroundGreer, T. L., Sunderajan, P., Grannemann, B. D., Kurian, B. T., & Trivedi, M. H. (2014) · Depression Research and Treatment · doi:10.1155/2014/627863 · Cited by 63 · cited 1×
“For example, in a 12-week open-label trial, duloxetine was found to significantly improve cognitive function, particularly psychomotor speed (71).”
BackgroundDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressants
Niciu, M. J., Mathews, D. C., Nugent, A. C., Ionescu, D. F., Furey, M. L., Richards, E. M., Machado-Vieira, R., & Zarate, C. A. (2014) · Depression and Anxiety · doi:10.1002/da.22224 · Cited by 45
Stotland, N. L. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.007 · Cited by 30 · cited 2×
“Clinically, cognition has been classified into four subdomains: (1) learning and memory, (2) attention and concentration, (3) executive function, and (4) processing speed.”
BackgroundSelection of cognitive tests for trials of therapeutic agents
Harrison, J. E., Lam, R. W., Baune, B. T., & McIntyre, R. S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30067-0 · Cited by 22
Self-citationMiskowiak, K. W., Kessing, L. V., Ott, C. V., Macoveanu, J., Harmer, C. J., Jørgensen, A., Revsbech, R., Jensen, H. M., Paulson, O. B., Siebner, H. R., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699615 · Cited by 16 · cited 9×
“happy faces, as well as in fear-specific functional connectivity between amygdala and occipito-temporal regions in response to single-session ECT treatment (64).”
BackgroundInfluential
Research works printed but not linked: 42
- 2017, Depression and Other Common Mental Disorders Global Health
- Jacobs, 2009, PMH31 measuring the economic burden of depression using patient records, Value Health, 12, A356, 10.1016/S1098-3015(10)74750-1 · doi:10.1016/s1098-3015(10)74750-1
- Lépine, 2011, The increasing burden of depression, Neuropsychiatric Dis Treatmen, 7, 3, 10.2147/NDT.S19617 · DOI · Paper page
- Zimmerman, 2006, Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined, Psychiatry Res, 141, 185, 10.1016/j.psychres.2005.05.016 · DOI
- Stedman, 2012, Stedman's Medical Dictionary for the Health Professions and Nursing.
- 2013, In Diagnostic and Statistical Manual of Mental Disorders
- Cserjési, 2009, Altered executive function in obesity. exploration of the role of affective states on cognitive abilities, Appetite., 52, 535, 10.1016/j.appet.2009.01.003 · DOI · Paper page
- Larochette, 2011, Additive Neurocognitive Deficits in Adults with attention-deficit/hyperactivity disorder and depressive symptoms, Arch Clin Neuropsychol., 26, 385, 10.1093/arclin/acr033 · DOI
- Mansur, 2014, Diabetes mellitus and disturbances in brain connectivity: abidirectional relationship?, Neuromol Med., 16, 658, 10.1007/s12017-014-8316-8 · DOI
- Thomas, 2009, A comparison of neurocognitive impairment in younger and older adults with major depression, Psychol Med., 39, 725, 10.1017/S0033291708004042 · DOI
- Gildengers, 2012, Cognition in older adults with bipolar disorder versus major depressive disorder, Bipolar Disord., 14, 198, 10.1111/j.1399-5618.2012.00995.x · DOI · Paper page
- Withall, 2010, A longitudinal study of cognitive function in melancholic and non-melancholic subtypes of major depressive disorder, J Affect Disord., 123, 150, 10.1016/j.jad.2009.07.012 · DOI
- Pan, 2017, Pharmacological treatment of cognitive symptoms in major depressive disorder, CNS Neurol Disord. - Drug Targets, 16, 1, 10.2174/1871527316666170919115100 · DOI
- Lemos-Miller, 2006, Depression and ethnicity as intermediary variables among dissociation, trauma-related cognitions, and PTSD Symptomatology in Youths, J Nervous Mental Dis., 194, 584, 10.1097/01.nmd.0000230407.12687.ba · DOI
- Airaksinen, 2007, Low episodic memory performance as a premorbid marker of depression: evidence from a 3-year follow-up, Acta Psychiatrica Scand., 115, 458, 10.1111/j.1600-0447.2006.00932.x · DOI · Paper page
- Park, 2018, Predicting antidepressant response using early changes in cognition: a systematic review, Behav Brain Res., 353, 154, 10.1016/j.bbr.2018.07.011 · DOI
- McIntyre, 2015, The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project, Comprehens Psychiatry, 56, 279, 10.1016/j.comppsych.2014.08.051 · DOI
- Ott, 2016, Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools, J Affect Disord., 190, 607, 10.1016/j.jad.2015.10.059 · DOI · Paper page
- Mackin, 2013, The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment, Am J Geriat Psychiatry, 21, 906, 10.1016/j.jagp.2013.01.021 · DOI
- Lee, 2013, Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients, Psychol Med., 43, 1161, 10.1017/S0033291712002127 · DOI · Paper page
- Naismith, 2011, Enhancing memory in late-life depression: the effects of a combined psychoeducation and cognitive training program, Am J Geriatr Psychiatry, 19, 240, 10.1097/JGP.0b013e3181dba587 · DOI
- Lemogne, 2012, Medial prefrontal cortex and the self in major depression, J Affect Disord., 136, e1, 10.1016/j.jad.2010.11.034 · DOI · Paper page
- Yoshimura, 2010, Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity, J Affect Disord., 122, 76, 10.1016/j.jad.2009.06.017 · DOI · Paper page
- Yoshimura, 2017, Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices, J Affect Disord., 208, 610, 10.1016/J.JAD.2016.10.017 · DOI
- Semkovska, 2010, Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis, 68, 568, 10.1016/j.biopsych.2010.06.009 · DOI · Paper page
- Miskowiak, 2014, “Hot” cognition in major depressive disorder: a systematic review, CNS Neurol Disord Drug Targets, 13, 1787, 10.2174/1871527313666141130205713 · DOI
- Miskowiak, 2007, Single dose antidepressant administration modulates the neural processing of self-referent personality trait words, NeuroImage, 37, 904, 10.1016/j.neuroimage.2007.05.036 · DOI
- Nathan, 2014, Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery, Curr Opin Pharmacol., 14, 54, 10.1016/j.coph.2013.11.009 · DOI
- Rasmussen, 2011, Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression, J ECT, 27, 51, 10.1097/YCT.0b013e3181da84c6 · DOI
- Ressler, 2001, Role of norepinephrine in the pathophysiology of neuropsychiatric disorders, CNS Spectrums., 6, 663, 10.1017/S1092852900001358 · DOI
- FDA Updates Trintellix® (vortioxetine) Label to Include Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in acute Major Depressive Disorder (MDD).2018
- Rowland, 2005, Selective cognitive impairments associated with NMDA receptor blockade in humans, Neuropsychopharmacology, 30, 633, 10.1038/sj.npp.1300642 · DOI · Paper page
- Krystal, 1999, Interactive effects of subanesthetic ketamine and haloperidol in healthy humans, Psychopharmacology, 145, 193, 10.1007/s002130051049 · DOI · Paper page
- Morgan, 2004, Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers, Neuropsychopharmacology., 29, 208, 10.1038/sj.npp.1300342 · DOI · Paper page
- Price, 2014, Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression, Depress Anxiety, 31, 335, 10.1002/da.22253 · DOI · Paper page
- Bunn, 2013, Erythropoietin, Cold Spring Harbor Perspect Med., 3, a011619, 10.1101/cshperspect.a011619 · DOI · Paper page
- Miskowiak, 2012, Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression, Psychopharmacology, 219, 687, 10.1007/s00213-011-2511-1 · DOI
- Sun, 2018, Exercise for cognitive symptoms in depression: a systematic review of interventional studies, Can J Psychiatry, 63, 115, 10.1177/0706743717738493 · DOI
- Reger, 2008, Intranasal insulin improves cognition and modulates -amyloid in early AD, Neurology., 70, 440, 10.1212/01.WNL.0000265401.62434.36 · DOI · Paper page
- McIntyre, 2012, A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder, Bipolar Disord., 14, 697, 10.1111/bdi.12006 · DOI · Paper page
- Craft, 2012, Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial, Archi Neurol., 69, 29, 10.1001/archneurol.2011.233 · DOI · Paper page
- Cha, 2017, A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder, J Affect Disord., 210, 57, 10.1016/j.jad.2016.12.006 · DOI
Cited by
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
Microglia regulation of synaptic plasticity and learning and memory
Zhou, M., Cornell, J., Salinas, S., & Huang, H.-Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.322423 · Cited by 548
“Microglial activation or dysfunction is associated with the progression of cognitive deficits in normal aging, neurodegenerative and neurological diseases such as Alzheimer’s disease (AD), traumatic brain injury (TBI) and HIV-associated neurocognitive disorder (HAND), and mental disorders including autism, stress and…”
BackgroundInfluentialAnimal models of major depression: drawbacks and challenges
Planchez, B., Surget, A., & Belzung, C. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02084-y · Cited by 480
Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435
Self-citationPaying attention to attention in depression
Keller, A. S., Leikauf, J. E., Holt-Gosselin, B., Staveland, B. R., & Williams, L. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0616-1 · Cited by 329
Metadata
- Authors
- Zuckerman, H., Pan, Z., Park, C., Brietzke, E., Musial, N., Shariq, A. S., Iacobucci, M., Yim, S. J., Lui, L. M. W., Rong, C., & McIntyre, R. S.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2018-12-04
- Volume
- 9
- Pages
- 655-655
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2902778000
- Cited by
- 252
- References
- 51
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.